Principles of Anti-Aging Combination Therapies

Anatoly Mayburd graduated from Moscow Institute of Chemical Technology after D.I Mendeleev in Moscow, Russia in chemical engineering, and in 1994-2001, he completed a PhD program at University of Illinois, Chicago, USA. In 2002, Dr. Mayburd joined the National Institute of Health, and National Cancer Institute working in pre-clinical drug design (2002-2006), publishing in high impact journals such as Cancer Research and Clinical Cancer Research. Anatoly developed the cancer target prioritization approach based on microarray data (published in Bioinformatics Oxford). Dr Mayburd was hired by the Defense Threat Reduction Agency (DTRA, 2006-2008), to address the pandemic H5N1. Dr. Mayburd became an affiliated scholar with George Mason University (2012-2024, GMU), conducting research in systems biology, dementia, aging, other chronic diseases, pandemic preparedness, and accelerated drug development (19 first author publications, 1 book chapter). At GMU, Dr Mayburd developed the ideas published in this book. Anatoly found the topic of longevity inspirational after 12 years of published research.